Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shunki Hirayama is active.

Publication


Featured researches published by Shunki Hirayama.


Journal of Thoracic Oncology | 2012

Prognostic Impact of CD204-Positive Macrophages in Lung Squamous Cell Carcinoma: Possible Contribution of Cd204-Positive Macrophages to the Tumor-Promoting Microenvironment

Shunki Hirayama; Genichiro Ishii; Kanji Nagai; Shotaro Ono; Motohiro Kojima; Chisako Yamauchi; Keiju Aokage; Tomoyuki Hishida; Junji Yoshida; Kenji Suzuki; Atsushi Ochiai

Introduction: Tumor-associated macrophages (TAMs) are recruited into cancer-induced stroma and produce a specific microenvironment for cancer progression. CD204 (+) TAMs are reportedly related to tumor progression and clinical outcome in some tumors. The aim of this study was to clarify the correlation between CD204 (+) TAMs and the clinicopathological features of lung squamous cell carcinoma. Methods: We investigated the relationships between the numbers of CD204 (+) TAMs and clinicopathological factors, microvessel density, and the numbers of Foxp3 (+) lymphocytes in 208 consecutively resected cases. We also examined the relationships between the numbers of CD204 (+) TAMs and the expression levels of cytokines involved in the migration and differentiation of CD204 (+) TAMs. Results: A high number of CD204 (+) TAMs in the stroma was significantly correlated with an advanced p-stage, T factor, N factor, and the presence of vascular and pleural invasion. A high number of CD204 (+) TAMs in the stroma was also a significant prognostic factor for all p-stages and p-stage I. Moreover, the numbers of CD204 (+) TAMs were correlated with the microvessel density and the numbers of Foxp3 (+) lymphocytes. A high number of CD204 (+) TAMs was strongly correlated with the tissue expression level of monocyte chemoattractant protein-1. CD204 (+) TAMs were shown to be significant independent prognostic factors in a multivariate analysis. Conclusions: CD204 (+) TAMs were an independent prognostic factor in lung squamous cell carcinoma. CD204 (+) TAMs, along with other tumor-promoting stromal cells such as regulatory T cells and endothelial cells, may create tumor-promoting microenvironments.


Cancer Science | 2013

Forkhead box P3 regulatory T cells coexisting with cancer associated fibroblasts are correlated with a poor outcome in lung adenocarcinoma

Tomonari Kinoshita; Genichiro Ishii; Nobuyoshi Hiraoka; Shunki Hirayama; Chisako Yamauchi; Keiju Aokage; Tomoyuki Hishida; Junji Yoshida; Kanji Nagai; Atsushi Ochiai

Recently, an association between tumor infiltrating Forkhead box P3 regulatory T cells (Treg) and an unfavorable prognosis has been clinically shown in some cancers, but the mechanism of Treg induction in the tumor microenvironment remains uncertain. The aims of the present study were to examine the relationship between Treg and patient outcome and to investigate whether Treg induction is influenced by the characteristics of cancer‐associated fibroblasts (CAF) in lung adenocarcinoma. The numbers of Treg in both the tumor stroma and the tumor nest were counted in 200 consecutive pathological stage I lung invasive adenocarcinoma specimens. To examine whether the characteristics of CAF influence Treg induction, we selected and cultured CAF from low Treg and high Treg adenocarcinoma. The number of Treg was much higher in the stroma than in the nest (P < 0.01). Patients with high Treg had a significantly poorer prognosis than those with low Treg (overall survival: P = 0.03; recurrence‐free survival: P = 0.02; 5‐year overall survival: 85.4% vs 93.0%). Compared with the CAF from low Treg adenocarcinoma, culture supernatant of the CAF from high Treg adenocarcinoma induced more Treg (P = 0.01). Also, CAF from high Treg adenocarcinoma expressed significantly higher mRNA levels of transforming growth factor‐β (P = 0.01) and vascular endothelial growth factor (P = 0.01), both of which are involved in Treg induction. Our studies suggest the possibility that CAF expressing immunoregulatory cytokines may induce Treg in the stroma, creating a tumor‐promoting microenvironment in lung adenocarcinoma that leads to a poor outcome.


Journal of Thoracic Oncology | 2018

Distinct clinicopathological characteristics and prognosis based on the presence of ground glass opacity component in clinical-stage IA lung adenocarcinoma

Aritoshi Hattori; Shunki Hirayama; Takeshi Matsunaga; Takuo Hayashi; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki

Introduction: We evaluated differences in the clinicopathologic characteristics and prognosis based on the presence of ground glass opacity (GGO) components in small‐sized lung adenocarcinoma. Methods: We retrospectively investigated 634 lung adenocarcinomas classed as c‐stage IA in the eighth edition TNM classification. Staging was defined according to the solid component size measured by thin‐section computed tomography. All tumors were grouped into either a GGO or solid group, based on the presence of a GGO component. Results: Of the cases, 215 (34%) were classed as c‐stage IA1 (T1mi: 88, T1a‐GGO: 102, T1a‐solid: 25), 255 (40%) as c‐stage IA2 (T1b‐GGO: 122, T1b‐solid: 133), and 164 (26%) as c‐stage IA3 (T1c‐GGO: 44, T1c‐solid: 120). Among the 546 c‐stage IA cases excluding the T1mi lesions, Cox regression analysis revealed that presence of GGO was an independently significant prognosticator (p = 0.024). The result was validated in 494 c‐stage IA lung adenocarcinomas with a nonpredominant GGO component, showing the presence of GGO as a significant prognosticator (p = 0.048). When we evaluated the prognostic impact of GGO presence in each clinical stage, the 5‐year overall survival (OS) was significantly different between the GGO and solid groups (IA1: 97.8% versus 86.6%, p = 0.026; IA2: 89.3% versus 75.2%, p = 0.007; IA3: 88.5% versus 62.3%, p = 0.003). Furthermore, the 5‐year overall survival b was distinct in parallel similar pathologic findings when comparing a lepidic versus an invasive component (IA1: 97.9% versus 85.6%, p = 0.031; IA2: 86.1% versus 69.4%, p = 0.007; IA3: 77.5% versus 55.8%, p < 0.001). Conclusions: Clinicopathologic and oncologic outcomes were disparate based on the presence of a GGO component in the eighth edition TNM classification of c‐stage IA lung adenocarcinoma.


Journal of Stroke & Cerebrovascular Diseases | 2017

Limb-Shaking Transient Ischemic Attack Induced by Middle Cerebral Artery Dissection after Lung Surgery

Daisuke Taniguchi; Yutaka Oji; Yuji Ueno; Shunki Hirayama; Mariko Fukui; Nobukazu Miyamoto; Kazuo Yamashiro; Ryota Tanaka; Kenji Suzuki; Nobutaka Hattori

We report a case of limb-shaking transient ischemic attack (TIA) caused by a dissection of the middle cerebral artery (MCA) following lung surgery under general anesthesia. An 81-year-old male patient who underwent lobectomy for lung cancer suddenly developed transient shaking movements of the neck and the left upper distal limb on postoperative day 1. On the basis of the double-barrel appearance of the right M1 segment of the MCA, a diagnosis of MCA dissection was made. Physicians should be aware that limb-shaking TIA is sometimes caused by MCA dissection and could be precipitated by any condition, including lung surgery under general anesthesia.


The Annals of Thoracic Surgery | 2017

Utility of Objective Chest Tube Management After Pulmonary Resection Using a Digital Drainage System

Kazuya Takamochi; Kota Imashimizu; Mariko Fukui; Tatsuo Maeyashiki; Mikiko Suzuki; Takuya Ueda; Hironori Matsuzawa; Shunki Hirayama; Takeshi Matsunaga; Shiaki Oh; Kenji Suzuki


Journal of Cardiothoracic and Vascular Anesthesia | 2017

A Combination of a Partial Anomalous Pulmonary Venous Connection (PAPVC) and a Lung Tumor Requiring Pulmonary Resection

Izumi Kawagoe; Masakazu Hayashida; Yusaku Nozumi; Takamitsu Banno; Shunki Hirayama; Kenji Suzuki; Daizoh Satoh; Yoshiyuki Naito; Eiichi Inada


The Japanese Journal of Thoracic and Cardiovascular Surgery | 2018

Case report of cardiac herniation after sleeve pneumonectomy with superior vena cava reconstruction

Mariko Fukui; Mikiko Suzuki; Izumi Kawagoe; Shunki Hirayama; Ryosuke Tachi; Yutaro Koike; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki


Journal of Thoracic Oncology | 2018

P3.16-25 Impact of Diabetes Mellitus on Survival Outcome in Patients with Pathological Stage IA Non-Small Cell Lung Cancer

Shunki Hirayama; Mariko Fukui; Aritoshi Hattori; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki


Journal of Thoracic Oncology | 2017

P3.04-023 Perioperative Management of Antiplatelet Therapy in Patients with Coronary Stent Who Need Thoracic Surgery: Topic: Miscellaneous I

Shunki Hirayama; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki


Interactive Cardiovascular and Thoracic Surgery | 2017

P-222THE PROGNOSIS OF LUNG ADENOCARCINOMA WITH CLINICAL STAGE 0-IA3 IN THE 8TH EDITION OF THE TNM CLASSIFICATION

Shunki Hirayama; Aritoshi Hattori; Mariko Fukui; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; K. Suzuki

Collaboration


Dive into the Shunki Hirayama's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge